PDS Biotechnology Corp
PDSBNasdaqCIK 1472091HealthcareFiscal year ends Dec 31
Reports and events: 360 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2123:59 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-040283 |
| 2026-10-2012:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-040181 |
| 2026-10-0612:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-038728 |
| 2026-09-2212:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-037298 |
| 2026-09-2101:56 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-397073 |
| 2026-09-2120:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-037234 |
| 2026-09-1420:10 ET | 8-K | 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-036489 |
| 2026-09-0812:35 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-035853 |
| 2026-09-0421:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-26-035809 |
| 2026-08-2520:08 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors | 0001140361-26-034320 |
| 2026-08-1920:52 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-26-033749 |
| 2026-08-1412:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-26-032947 |
| 2026-08-1320:20 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001140361-26-032824 |
| 2026-08-1312:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-032650 |
| 2026-08-1112:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-032142 |
| 2026-07-3120:15 ET | 8-K | 3.01 Delisting notice | 0001140361-26-030497 |
| 2026-06-2620:15 ET | DEF 14A | Proxy statementPeriod 2026-08-10 | 0001140361-26-026564 |
| 2026-06-1520:00 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001140361-26-025207 |
| 2026-06-1512:00 ET | 8-K | 8.01 Other events | 0001140361-26-025121 |
| 2026-06-0219:35 ET | 8-K | 8.01 Other events | 0001140361-26-023698 |
| 2026-05-1420:07 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001140361-26-021286 |
| 2026-05-1311:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-020934 |
| 2026-05-0116:26 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001140361-26-018464 |
| 2026-04-2820:30 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001140361-26-017461 |
| 2026-04-2420:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-016684 |
| 2026-04-1512:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-014693 |
| 2026-03-3021:39 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001140361-26-012030 |
| 2026-03-3011:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-011862 |
| 2026-03-0317:01 ET | 8-K | 3.01 Delisting notice | 0001140361-26-007478 |
| 2026-02-2321:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-006410 |
| 2026-02-2013:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-006229 |
| 2026-01-2813:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-002608 |
| 2026-01-2213:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-001958 |
| 2026-01-0913:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-000786 |
| 2025-12-0913:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-044940 |
| 2025-12-0213:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-043889 |
| 2025-11-1321:08 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001140361-25-041976 |
| 2025-11-1312:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-041805 |
| 2025-11-1214:12 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-041563 |
| 2025-11-1013:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-041286 |
| 2025-10-2912:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-039656 |
| 2025-09-1812:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-035339 |
| 2025-08-2520:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-032503 |
| 2025-08-2512:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-032433 |
| 2025-08-1320:35 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001140361-25-030825 |
| 2025-08-1311:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-030701 |
| 2025-07-1012:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-025409 |
| 2025-06-2520:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-023644 |
| 2025-06-1120:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-25-022212 |
| 2025-06-0212:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-021032 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.